• C.D.C. Panel Keeps Pause on Use of J&J Vaccine, Weighing Risks

    29 days ago - By NY Times

    An advisory committee debated the very few cases of a rare blood disorder and worried about the suspension's effect on global needs for a one-shot, easy-to-ship vaccine.
    Read more ...

     

  • The AstraZeneca and J&J vaccines share the same technology. It could explain why both have possible links to rare blood clots

    The AstraZeneca and J&J vaccines share the same technology. It could explain why both have possible links to rare blood clots

    29 days ago - By Business Insider

    Summary List Placement When coronavirus vaccines were rolled out to the public, regulators knew they would need to watch out for extremely rare reactions. Although clinical trials had shown the shots to be safe among tens of thousands of people, the world was about to vaccinate tens of millions more.
    Their vigilance paid off earlier this month when European regulators announced that rare blood clots might be an uncommon side effect of AstraZeneca's vaccine. Then on Tuesday, US regulators recommended a pause in the distribution of Johnson & Johnson's vaccine due to six reports of the same...
    Read more ...